查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1919306

NMN膠囊市場：依產品類型、劑量、應用、最終用戶和分銷管道分類－2026-2032年全球預測

NMN Capsule Market by Product Type, Dosage Strength, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，NMN 膠囊市場價值將達到 23.1 億美元，到 2026 年將成長至 24.5 億美元，到 2032 年將達到 34.5 億美元，複合年成長率為 5.90%。

關鍵市場統計數據
基準年 2025 23.1億美元
預計年份：2026年 24.5億美元
預測年份 2032 34.5億美元
複合年成長率 (%) 5.90%

為決策者提供關於NMN膠囊市場基本要素的全面指導，涵蓋轉化科學、消費者需求和商業策略。

引言部分將NMN膠囊市場定位為科學進步、消費者對延年益壽解決方案的需求以及不斷變化的監管重點的交匯點。煙醯胺腺嘌呤二核苷酸（NMN）研究的最新進展以及消費者對細胞健康認知的提升，使得NMN從一種小眾膳食補充劑發展成為產品開發商、臨床醫生和分銷合作夥伴的戰略考慮因素。本節將闡明研究範圍，重點關注產品配方、分銷趨勢、治療和健康促進應用以及影響產品創新的競爭格局。

配方技術的進步、監管審查的加強以及消費者期望的改變，正在如何重塑產品開發、行銷和分銷策略？

NMN膠囊市場的變化反映了技術的成熟、監管政策的調整以及消費者對循證長壽干預措施的日益重視。合成效率和穩定性的突破性進展使得將NMN與其他活性成分結合的新產品得以問世，從而實現多樣化的健康益處。同時，監管機構對成分聲明的審查日益嚴格，迫使生產商加強臨床檢驗投入，並更加謹慎地進行市場推廣，以確保產品在不同地區的市場准入。

2025年關稅調整和貿易政策轉變對NMN膠囊相關人員的採購、定價和供應鏈韌性的策略影響

2025年關稅調整和貿易政策變化帶來的累積影響，為全球供應鏈中營運的NMN膠囊相關人員帶來了新的策略考量。關稅上調、原料類別重新分類以及海關單證要求的加強，都對原料、成品和包裝組件的到岸成本產生了影響，迫使採購部門重新評估供應商關係和緊急庫存。

通路、配方組合、應用重點、終端用戶畫像和給藥策略與商業性優先事項聯繫起來的詳細細分分析

細分市場分析揭示了基於分銷管道、產品類型、應用、最終用戶和劑量強度的細微市場路徑。分銷管道包括直銷、醫療服務提供者、線上零售、藥局/藥房和零售商店。線上零售進一步細分為自有品牌網站、電商平台和第三方市場；藥局/藥局分為連鎖藥局和獨立藥局；零售商店包括保健食品店、專賣店和超級市場/大賣場。每個管道都具有獨特的優勢：直銷便於利潤管理和客戶資料收集；醫療服務提供者管道提供臨床信譽；線上零售支援快速規模化和個人化；而入駐藥局和零售商店則有助於在普通消費者群體中建立信譽和認可度。

影響美洲、歐洲、中東和非洲以及亞太地區市場准入、合規和通路發展的區域商業性和監管趨勢

區域趨勢在美洲、歐洲、中東和非洲以及亞太地區的市場中，對產品策略、監管應對措施和上市順序的製定起著關鍵作用。美國市場對實證健康產品的需求強勁，這得益於其強大的直銷生態系統和日益成長的臨床關注。這促使創新者優先考慮清晰的功效標籤、高品質的包裝和便於訂閱的模式。同時，歐洲、中東和非洲的法規環境要求企業仔細協調統一的標籤規則、當地衛生監管機構的要求以及不同的報銷框架，因此鼓勵企業採取跨司法管轄區的合規策略並與當地經銷商建立合作關係。

競爭格局分析，重點在於NMN膠囊市場主要企業的差異化策略、夥伴關係模式和品質保證重點。

NMN膠囊市場的競爭格局呈現出多元化的特點，既有成熟的膳食補充劑公司，也有專注於創新的特色補充劑企業，還有從原料供應商拓展到成品領域的企業。主要企業透過投資臨床研究、專有配方技術、擴大生產規模和拓展分銷網路來脫穎而出。有些公司致力於合成高純度NMN，並專注於供應鏈的透明度，以贏得醫療保健專業人士和眼光獨到的消費者的信任。同時，其他公司則專注於將NMN與Coenzyme Q10、白藜蘆醇和其他營養成分協同作用，以針對特定的生理路徑競爭。

為領導者提供切實可行的跨職能建議，以加強證據產生、通路執行和供應鏈韌性，進而加速商業化進程。

針對產業領導者的具體建議包括：優先考慮證據產生、通路專屬商業化以及營運韌性。企業應投資於轉化臨床研究，研究終點與目標應用相符，例如細胞老化、認知健康和心臟標幟物，以增強產品功效並促進專業人士的採納。除了臨床研究之外，品牌還應清楚展示透明的供應鏈實踐和第三方檢測數據，以建立消費者信任並確保藥房和醫療保健提供者的合規性。

採用透明、多維度的研究途徑，結合專家訪談、文獻綜述和情境分析，以檢驗可操作的市場洞察。

本調查方法結合了質性研究的一手和二手資料，並輔以專家檢驗，以確保研究結果的穩健性和相關性。一手研究包括對配方負責人、法規專家、採購主管和通路經理進行結構化訪談，以收集配方挑戰、合規障礙和市場推廣趨勢的第一線觀點。二手分析則檢視了同行評審文獻、專利趨勢和已發布的監管指南，以闡明臨床主題和成分分類趨勢的背景。這些證據來源透過三角驗證法進行整合，使從業者的見解與已記錄的科學發現和政策趨勢相吻合。

整合策略要務，強調證據、監管彈性和目標管道執行，以此作為永續NMN膠囊商業化的基礎。

報告最後總結了以下關鍵發現：NMN膠囊正處於新興科學與商業性機會的策略交匯點，但其成功取決於可靠的證據、監管方面的前瞻性以及針對特定管道的策略。優先考慮嚴格的臨床檢驗、透明的品管和適應性供應鏈設計的公司將建立永續的競爭優勢。此外，按分銷管道、製劑類型、應用、最終用戶和劑量進行詳細細分，將有助於更精準地分配研發投資和行銷資源。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的NMN膠囊市場

  • NMN和Coenzyme Q10組合產品
  • 僅限NMN
  • 將NMN與其他營養素結合使用
  • 含有NMN、白藜蘆醇和Coenzyme Q10
  • NMN和白藜蘆醇組合產品

9. 依劑量強度分類的NMN膠囊市場

  • 125-250 mg
  • 250-500 mg
  • 超過500毫克
  • 少於125毫克

第10章 按應用分類的NMN膠囊市場

  • 抗衰老
    • 細胞老化
    • 關節健康
    • 皮膚老化
  • 美容及個人護理
  • 心血管健康
  • 認知健康
  • 運動營養
  • 體重管理

第11章 以最終用戶分類的NMN膠囊市場

  • 美容健康中心
  • 健身中心
  • 醫院和診所
  • 家用

第12章 NMN膠囊市場按分銷管道分類

  • 直銷
  • 醫療保健提供者
  • 線上零售
    • 品牌官方網站
    • 電子商務平台
    • 第三方市場
  • 藥房和藥品商店
    • 連鎖藥局
    • 獨立藥房
  • 零售店
    • 健康食品店
    • 專賣店
    • 超級市場和大賣場

第13章 各地區NMN膠囊市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 NMN膠囊市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國NMN膠囊市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國NMN膠囊市場

第17章中國NMN膠囊市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ChromaDex, Inc.
  • Doctor's Best, Inc.
  • Douglas Laboratories, LLC
  • Elysium Health Inc.
  • Garden of Life, LLC
  • GNC Holdings, LLC
  • Healthy Origins LLC
  • Herbalife Nutrition Ltd.
  • Integrative Therapeutics, LLC
  • Jarrow Formulas, Inc.
  • Life Extension Foundation, Inc.
  • MAAC10 Formulas, Inc.
  • Metrolex Laboratory Pvt. Ltd.
  • Nature's Bounty Co.
  • NOW Health Group, Inc.
  • Nutra Pharma Corporation
  • NutraBio Labs, Inc.
  • Rare Nutrition Ltd.
  • Solgar, Inc.
  • Sports Research Corporation
  • Swanson Health Products, Inc.
  • Thorne HealthTech, Inc.
Product Code: MRR-F14BA1B341A3

The NMN Capsule Market was valued at USD 2.31 billion in 2025 and is projected to grow to USD 2.45 billion in 2026, with a CAGR of 5.90%, reaching USD 3.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.31 billion
Estimated Year [2026] USD 2.45 billion
Forecast Year [2032] USD 3.45 billion
CAGR (%) 5.90%

Comprehensive orientation to NMN capsule market fundamentals connecting translational science, consumer demand, and commercial strategy for decision makers

The introduction frames the NMN capsule landscape as a convergence of scientific progress, consumer demand for longevity solutions, and evolving regulatory attention. Recent advances in nicotinamide mononucleotide research, combined with growing consumer literacy about cellular health, have elevated NMN from a niche nutraceutical into a strategic consideration for product developers, clinicians, and channel partners. This section establishes the scope of inquiry, focusing on product formulations, distribution dynamics, therapeutic and wellness applications, and the competitive environment shaping product innovation.

Readers will gain orientation on key terminologies, prevalent formulation archetypes, and the primary drivers influencing purchasing decisions across distinct end users. The narrative also highlights the interplay between clinical evidence and commercial adoption, clarifying how translational science affects labeling, claims, and route-to-market choices. Finally, the introduction sets expectations for the deeper analytical sections that follow, emphasizing practical implications for R&D prioritization, channel strategy, and stakeholder engagement while positioning the reader to interpret subsequent findings with commercial clarity.

How advances in formulation, regulatory scrutiny, and evolving consumer expectations are reshaping product development, marketing, and distribution strategies

Shifts in the NMN capsule landscape reflect technological maturation, regulatory recalibration, and changing consumer priorities toward evidence-backed longevity interventions. Breakthroughs in synthesis efficiency and stability have enabled new combination products that marry NMN with complementary actives to target diverse health outcomes. Concurrently, regulatory agencies are increasingly scrutinizing ingredient claims, driving manufacturers to invest in clinical validation and more conservative marketing language to preserve access across jurisdictional frameworks.

Consumer behavior is also transforming: adoption is moving from early adopters toward health-conscious mainstream consumers who expect clear efficacy narratives and safe, convenient dosing formats. Digital health ecosystems and direct-to-consumer platforms have amplified product discovery and peer-driven endorsement, creating opportunities for brands that can demonstrate transparency and clinical relevance. As a result, incumbents and new entrants alike are reallocating budgets toward clinical research partnerships, targeted channel expansion, and packaging innovations that reduce friction for trial and repeat purchase. These transformative shifts collectively demand agile strategy, cross-functional collaboration, and a readiness to iterate product offerings in response to emerging evidence and regulatory guidance.

Strategic implications of 2025 tariff adjustments and trade policy shifts on sourcing, pricing, and supply chain resilience for NMN capsule stakeholders

The cumulative impact of tariff adjustments and trade policy changes in 2025 has introduced additional strategic considerations for NMN capsule stakeholders operating across global supply chains. Tariff expansions, reclassifications of ingredient categories, and increased customs documentation requirements have affected the landed cost of raw materials, finished goods, and packaging components, prompting procurement teams to reassess supplier relationships and contingency inventories.

In response, manufacturers have pursued a range of mitigation tactics, including nearshoring of critical synthesis processes, qualifying alternative suppliers with robust quality systems, and negotiating longer-term contracts to stabilize input pricing. Retailers and online platforms have adjusted pricing strategies to preserve margin while maintaining competitive shelf prices for consumers. Regulatory compliance burdens tied to import controls have also emphasized the importance of traceability, batch-level documentation, and proactive engagement with customs authorities. Looking ahead, organizations that integrate tariff scenario planning into product lifecycle management and trade compliance processes will be better positioned to absorb shocks and sustain market momentum despite shifting trade regimes.

Detailed segmentation insights connecting distribution pathways, formulation combinations, application focus, end-user profiles, and dosage strategies to commercial priorities

Segmentation analysis reveals nuanced pathways to market based on distribution channel, product type, application, end user, and dosage strength. Distribution channels include direct sales, healthcare providers, online retail, pharmacy drug stores, and retail stores, with online retail further divided into brand websites, ecommerce platforms, and third-party marketplaces, pharmacy drug stores split between chain drug stores and independent pharmacies, and retail stores encompassing health food stores, specialty stores, and supermarkets and hypermarkets. Each channel presents distinct advantages: direct sales enable margin control and customer data capture; healthcare provider channels offer clinical credibility; online retail supports rapid scale and personalization; pharmacy and retail store presences reinforce trust and visibility among mainstream consumers.

Product type segmentation covers NMN-only formulations as well as combination products such as NMN with Coenzyme Q10, NMN with resveratrol, NMN with resveratrol and Coenzyme Q10, and other nutrient combinations. These formulation differences dictate claims, stability needs, and manufacturing complexity, with combination products often targeting synergistic mechanisms to support anti-aging, cardiovascular, cognitive, sports nutrition, or weight management applications. Application-focused segmentation highlights anti-aging subdomains like cellular aging, joint health, and skin aging alongside broader categories including beauty and personal care, cardiovascular health, cognitive health, sports nutrition, and weight management, each driving distinct positioning and evidence requirements.

End-user segmentation spans beauty wellness centers, fitness centers, hospitals and clinics, and household consumers, shaping distribution priorities and educational outreach. Dosage strength tiers include less than 125 mg, 125-250 mg, 250-500 mg, and greater than 500 mg, influencing product design, tablet or capsule size, and dosing frequency. Understanding how these segments intersect enables companies to tailor formulations, regulatory strategies, and channel investments that align with consumer expectations and clinical objectives.

Regional commercial and regulatory dynamics across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence market entry, compliance, and channel deployment

Regional dynamics play a key role in shaping product strategy, regulatory approaches, and go-to-market sequencing across the Americas, Europe Middle East and Africa, and Asia-Pacific markets. The Americas market displays a strong appetite for evidence-based wellness products, supported by a robust direct-to-consumer ecosystem and growing clinical interest, which encourages innovators to prioritize clear claims, high-quality packaging, and subscription-friendly formats. In contrast, regulatory environments across Europe, the Middle East, and Africa require careful navigation of harmonized labeling rules, local health authority requirements, and varying reimbursement frameworks, prompting multi-jurisdictional compliance strategies and partnerships with local distributors.

Asia-Pacific presents both rapid demand growth and diverse regulatory landscapes; market entrants must account for country-level differences in approval pathways, import controls, and consumer preferences for traditional health modalities. Across all regions, logistics considerations-especially in light of tariff changes and supply chain realignment-drive decisions about manufacturing footprints and inventory buffers. Regional commercialization plans that incorporate tailored messaging, local evidence generation, and partnerships with healthcare stakeholders will be essential for sustainable adoption and reputational trust in each geography.

Competitive landscape analysis highlighting differentiation strategies, partnership models, and quality assurance priorities among NMN capsule market leaders

Competitive dynamics in the NMN capsule arena are characterized by a mixture of established nutraceutical companies, specialty supplement innovators, and ingredient suppliers expanding into finished goods. Leading firms are differentiating through clinical investments, proprietary formulation technologies, manufacturing scale, and distribution reach. Some players emphasize high-purity NMN synthesis and supply-chain transparency to build trust with healthcare professionals and discerning consumers, while others compete on formulation synergies that combine NMN with coenzyme Q10, resveratrol, or other nutrients to target specific physiological pathways.

Partnerships between ingredient manufacturers and finished-product brands have become more common as a means to accelerate time-to-market and validate product performance. Retail and pharmacy channels favor suppliers that demonstrate quality assurance through third-party testing and robust stability data. Meanwhile, digital-native brands are leveraging personalized marketing and subscription models to cultivate recurring revenue and direct consumer insights. Organizations that balance scientific credibility with effective commercialization capabilities-spanning manufacturing, regulatory compliance, and omnichannel distribution-are better positioned to lead in an increasingly competitive landscape.

Practical, cross-functional recommendations for leaders to strengthen evidence generation, channel execution, and supply chain resilience to accelerate commercialization

Actionable recommendations for industry leaders prioritize evidence generation, channel-tailored commercialization, and operational resilience. Organizations should invest in translational clinical studies that align endpoints with target applications such as cellular aging, cognitive health, or cardiovascular markers, thereby strengthening product claims and professional adoption. Parallel to clinical work, brands must articulate transparent supply chain practices and third-party test data to build consumer trust and meet pharmacy and healthcare provider standards.

On the commercial front, leaders should adopt a channel-first go-to-market playbook: direct sales and online retail can accelerate consumer acquisition, while pharmacy and clinic partnerships support credibility and scale among mainstream audiences. Formulation strategies should balance potency and convenience, aligning dosage strength with evidence and consumer tolerance. Finally, risk mitigation measures-such as supplier diversification, nearshore manufacturing options, and integrated tariff scenario planning-will reduce vulnerability to trade disruptions. Implementing these recommendations requires cross-functional governance and investment in capabilities that translate scientific insight into scalable, compliant products and compelling commercial experiences.

Transparent, multi-method research approach combining primary expert interviews, literature synthesis, and scenario analysis to validate practical market insights

The research methodology combines primary and secondary qualitative inquiry with targeted expert validation to ensure robustness and relevance. Primary engagement included structured interviews with formulators, regulatory specialists, procurement leaders, and channel managers to capture first-hand perspectives on formulation challenges, compliance hurdles, and route-to-market dynamics. Secondary analysis reviewed peer-reviewed literature, patent activity, and public regulatory guidance to contextualize clinical themes and ingredient classification trends. These evidence streams were synthesized using a triangulation approach to reconcile practitioner insights with documented science and policy developments.

Analytical frameworks applied in the study encompassed value chain mapping, scenario analysis for trade and tariff impacts, and channel economics modeling to evaluate distribution trade-offs. Findings were validated through iterative consultations with industry stakeholders to ensure the final analysis reflects market realities, operational constraints, and strategic options available to decision-makers. Transparency in assumptions and the inclusion of sensitivity checks underpin the reliability of the conclusions and the practical recommendations provided.

Synthesis of strategic imperatives underscoring evidence, regulatory agility, and targeted channel execution as the foundation for sustainable NMN capsule commercialization

The conclusion synthesizes the report's core implications: NMN capsules occupy a strategic intersection of emerging science and commercial opportunity, but success hinges on credible evidence, regulatory foresight, and channel-specific strategies. Companies that prioritize rigorous clinical validation, transparent quality practices, and adaptive supply chain design will establish durable competitive advantages. Additionally, nuanced segmentation by distribution channel, formulation type, application, end user, and dosage strength enables more precise targeting of R&D investments and marketing resources.

As the market evolves, decision-makers should maintain a posture of continuous learning, scanning for new clinical findings, regulatory updates, and shifts in consumer preferences. By integrating research insights with agile commercialization processes, organizations can reduce time-to-adoption, manage regulatory risk, and create compelling value propositions for both professional and consumer audiences. The pathway forward requires disciplined execution across science, operations, and market engagement to translate potential into sustainable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NMN Capsule Market, by Product Type

  • 8.1. Nmn Coenzyme Q10 Combination
  • 8.2. Nmn Only
  • 8.3. Nmn Other Nutrient Combination
  • 8.4. Nmn Resveratrol Coenzyme Q10 Combination
  • 8.5. Nmn Resveratrol Combination

9. NMN Capsule Market, by Dosage Strength

  • 9.1. 125-250 Mg
  • 9.2. 250-500 Mg
  • 9.3. Greater Than 500 Mg
  • 9.4. Less Than 125 Mg

10. NMN Capsule Market, by Application

  • 10.1. Anti Aging
    • 10.1.1. Cellular Aging
    • 10.1.2. Joint Health
    • 10.1.3. Skin Aging
  • 10.2. Beauty Personal Care
  • 10.3. Cardiovascular Health
  • 10.4. Cognitive Health
  • 10.5. Sports Nutrition
  • 10.6. Weight Management

11. NMN Capsule Market, by End User

  • 11.1. Beauty Wellness Centers
  • 11.2. Fitness Centers
  • 11.3. Hospitals Clinics
  • 11.4. Household

12. NMN Capsule Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Healthcare Providers
  • 12.3. Online Retail
    • 12.3.1. Brand Websites
    • 12.3.2. Ecommerce Platforms
    • 12.3.3. Third Party Marketplaces
  • 12.4. Pharmacy Drug Stores
    • 12.4.1. Chain Drug Stores
    • 12.4.2. Independent Pharmacies
  • 12.5. Retail Stores
    • 12.5.1. Health Food Stores
    • 12.5.2. Specialty Stores
    • 12.5.3. Supermarkets Hypermarkets

13. NMN Capsule Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. NMN Capsule Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. NMN Capsule Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States NMN Capsule Market

17. China NMN Capsule Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ChromaDex, Inc.
  • 18.6. Doctor's Best, Inc.
  • 18.7. Douglas Laboratories, LLC
  • 18.8. Elysium Health Inc.
  • 18.9. Garden of Life, LLC
  • 18.10. GNC Holdings, LLC
  • 18.11. Healthy Origins LLC
  • 18.12. Herbalife Nutrition Ltd.
  • 18.13. Integrative Therapeutics, LLC
  • 18.14. Jarrow Formulas, Inc.
  • 18.15. Life Extension Foundation, Inc.
  • 18.16. MAAC10 Formulas, Inc.
  • 18.17. Metrolex Laboratory Pvt. Ltd.
  • 18.18. Nature's Bounty Co.
  • 18.19. NOW Health Group, Inc.
  • 18.20. Nutra Pharma Corporation
  • 18.21. NutraBio Labs, Inc.
  • 18.22. Rare Nutrition Ltd.
  • 18.23. Solgar, Inc.
  • 18.24. Sports Research Corporation
  • 18.25. Swanson Health Products, Inc.
  • 18.26. Thorne HealthTech, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NMN CAPSULE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NMN CAPSULE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NMN CAPSULE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NMN CAPSULE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NMN CAPSULE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NMN CAPSULE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NMN CAPSULE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NMN CAPSULE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NMN CAPSULE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NMN CAPSULE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NMN CAPSULE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN COENZYME Q10 COMBINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN COENZYME Q10 COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN COENZYME Q10 COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN ONLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN ONLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN OTHER NUTRIENT COMBINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN OTHER NUTRIENT COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN OTHER NUTRIENT COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN RESVERATROL COENZYME Q10 COMBINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN RESVERATROL COENZYME Q10 COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN RESVERATROL COENZYME Q10 COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN RESVERATROL COMBINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN RESVERATROL COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NMN CAPSULE MARKET SIZE, BY NMN RESVERATROL COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NMN CAPSULE MARKET SIZE, BY 125-250 MG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NMN CAPSULE MARKET SIZE, BY 125-250 MG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NMN CAPSULE MARKET SIZE, BY 125-250 MG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NMN CAPSULE MARKET SIZE, BY 250-500 MG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NMN CAPSULE MARKET SIZE, BY 250-500 MG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NMN CAPSULE MARKET SIZE, BY 250-500 MG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NMN CAPSULE MARKET SIZE, BY GREATER THAN 500 MG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NMN CAPSULE MARKET SIZE, BY GREATER THAN 500 MG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NMN CAPSULE MARKET SIZE, BY GREATER THAN 500 MG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NMN CAPSULE MARKET SIZE, BY LESS THAN 125 MG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NMN CAPSULE MARKET SIZE, BY LESS THAN 125 MG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NMN CAPSULE MARKET SIZE, BY LESS THAN 125 MG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NMN CAPSULE MARKET SIZE, BY ANTI AGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NMN CAPSULE MARKET SIZE, BY ANTI AGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NMN CAPSULE MARKET SIZE, BY ANTI AGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NMN CAPSULE MARKET SIZE, BY CELLULAR AGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NMN CAPSULE MARKET SIZE, BY CELLULAR AGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NMN CAPSULE MARKET SIZE, BY CELLULAR AGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NMN CAPSULE MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NMN CAPSULE MARKET SIZE, BY JOINT HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NMN CAPSULE MARKET SIZE, BY JOINT HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NMN CAPSULE MARKET SIZE, BY SKIN AGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NMN CAPSULE MARKET SIZE, BY SKIN AGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NMN CAPSULE MARKET SIZE, BY SKIN AGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NMN CAPSULE MARKET SIZE, BY BEAUTY PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NMN CAPSULE MARKET SIZE, BY BEAUTY PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NMN CAPSULE MARKET SIZE, BY BEAUTY PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NMN CAPSULE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NMN CAPSULE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NMN CAPSULE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NMN CAPSULE MARKET SIZE, BY COGNITIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NMN CAPSULE MARKET SIZE, BY COGNITIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NMN CAPSULE MARKET SIZE, BY COGNITIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NMN CAPSULE MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NMN CAPSULE MARKET SIZE, BY SPORTS NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NMN CAPSULE MARKET SIZE, BY SPORTS NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NMN CAPSULE MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NMN CAPSULE MARKET SIZE, BY WEIGHT MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NMN CAPSULE MARKET SIZE, BY WEIGHT MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NMN CAPSULE MARKET SIZE, BY BEAUTY WELLNESS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NMN CAPSULE MARKET SIZE, BY BEAUTY WELLNESS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NMN CAPSULE MARKET SIZE, BY BEAUTY WELLNESS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NMN CAPSULE MARKET SIZE, BY FITNESS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NMN CAPSULE MARKET SIZE, BY FITNESS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NMN CAPSULE MARKET SIZE, BY FITNESS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NMN CAPSULE MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NMN CAPSULE MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NMN CAPSULE MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NMN CAPSULE MARKET SIZE, BY HOUSEHOLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NMN CAPSULE MARKET SIZE, BY HOUSEHOLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NMN CAPSULE MARKET SIZE, BY HOUSEHOLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NMN CAPSULE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NMN CAPSULE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NMN CAPSULE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NMN CAPSULE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NMN CAPSULE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NMN CAPSULE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NMN CAPSULE MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NMN CAPSULE MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NMN CAPSULE MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NMN CAPSULE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NMN CAPSULE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NMN CAPSULE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NMN CAPSULE MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NMN CAPSULE MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NMN CAPSULE MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NMN CAPSULE MARKET SIZE, BY CHAIN DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NMN CAPSULE MARKET SIZE, BY CHAIN DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NMN CAPSULE MARKET SIZE, BY CHAIN DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NMN CAPSULE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NMN CAPSULE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NMN CAPSULE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NMN CAPSULE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NMN CAPSULE MARKET SIZE, BY RETAIL STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NMN CAPSULE MARKET SIZE, BY RETAIL STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NMN CAPSULE MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NMN CAPSULE MARKET SIZE, BY HEALTH FOOD STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NMN CAPSULE MARKET SIZE, BY HEALTH FOOD STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NMN CAPSULE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NMN CAPSULE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NMN CAPSULE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NMN CAPSULE MARKET SIZE, BY SUPERMARKETS HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NMN CAPSULE MARKET SIZE, BY SUPERMARKETS HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NMN CAPSULE MARKET SIZE, BY SUPERMARKETS HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NMN CAPSULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS NMN CAPSULE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL NMN CAPSULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 208. GCC NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 211. GCC NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 217. GCC NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 241. G7 NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. G7 NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. G7 NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 246. G7 NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 247. G7 NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. NATO NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 253. NATO NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. NATO NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. NATO NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 257. NATO NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL NMN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES NMN CAPSULE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA NMN CAPSULE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA NMN CAPSULE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA NMN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA NMN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA NMN CAPSULE MARKET SIZE, BY ANTI AGING, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA NMN CAPSULE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA NMN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA NMN CAPSULE MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA NMN CAPSULE MARKET SIZE, BY PHARMACY DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA NMN CAPSULE MARKET SIZE, BY RETAIL STORES, 2018-2032 (USD MILLION)